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1. INTRODUCTION 
 
India has a good climatic condition and provide more natural source, this promise to 
cure and prevent almost most of disease .Being in a stressful life style, most of the people 
experiences hair loss and they feel themselves less comfortable among others, As a way of 
finding a cure to it, they started using many synthetic lotions and many other preparations 
including hair transplantation technique. As the peak of their curiosity, they pick the most 
harm full treatment, it gives the person not only hair him/her needs, but also gifts him/her 
with may health problem and most shocking turns to be lethal. This work under the topic of 
“Hair growth; Herbs prove promising in hair growth. 
 
Now a day the diffuse hair loss is a common problem among the people between the 
of age 18 to 50 due to various health disorder, synthetic drug side effect, stress, malnutrition. 
The herb promise to cure the problem but single plant some time inadequate to produce quick 
benefit that Way to produce adequate effect by combining the plant by advance developed 
technology to provide more efficient effect. 
 
Herbal medicine is defined as the branch of science in which plant based formulations 
are used to alleviate the diseases. It is also known as botanical medicine or phytomedicine. In 
the early twentieth century herbal medicine was prime healthcare system as antibiotics or 
analgesics were not available. With increasing use of allopathic system of medicine, herbal 
medicine gradually lost its popularity among the people and the success of allopathic system 
was based on the fast therapeutic actions of synthetic drugs. 
1.1. HAIR LOSS 
Hair loss is known that diseases due to the various causes like the Nutritional 
deficiency, Hormonal imbalance, autoimmune disorder, Stress and Chemotherapy.  
1.1.1. Nutritional Deficiency1 
 Protein deficiency like the atrophy of hair follicles in protein-energy 
malnutrition diseases such as Marasmus and Kwashiorkar, Both diseases 
cause fine or brittle hair and alopecia instigated by telogen effluvium. 
 Zinc deficiency may result in dry and brittle hair and diffuse or patchy 
alopecia that worsens over time. 
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 Selenium deficiency may causes alopecia and a hypo-pigmentation of the 
hair and skin. 
 Vitamin A deficiency may cause excessive keratinization of the hair 
follicles, presenting keratin plugs. 
 A lack of biotin is a severe, even lethal deficiency in foetuses, but in those 
infants who do survive, biotin deficiency’s clinical signs include universal 
alopecia. 
 The most common diet deficiency, iron deficiency, may also result in 
alopecia. 
 
1.1.2. Hormone imbalance   
 Androgenetic alopecia 1,2,3  
  In consequence of circulating testosterone being converted to 
Dihydrotestosterone (DHT) by the enzyme 5α-reductase. Although DHT may 
support beard, chest, and axillary hair growth, it has a very different effect when it 
binds to the androgen receptor on certain hair follicles of the scalp. The binding 
shortens the growth phase of the hair follicles and lengthens the telogen phase, 
resulting in finer, lighter, and shorter hairs over time. Androgenetic alopecia is more 
common among men and follows a trademark pattern of balding beginning with a 
receding bitemporal hairline and then a loss of hair at the crown of the head. 
 
1.1.3. Autoimmune Disorder 4,5,6,7 
 Alopecia areata is another relatively common hair disorder occurring in 
healthy men and women. 
 Alopecia areata can cause hair loss ranging from small, patchy areas of 
baldness on the scalp to a complete loss of hair on the entire body. A 
lymphocytic infiltrate around hair follicles; the infiltrate consists mostly of 
helper-T cells. 
 Activated CD4 and CD8 lymphocytes are likely key players in the 
pathogenesis of alopecia areata. 
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 Alopecia areata patients may experience full hair re-growth during their 
lifetime, but many lose hair permanently.  
1.1.4. Psychosocial effects of hair loss 1 
 
Although hair loss is often a clinical manifestation of a serious internal stress 
or illness, hair loss itself is sometimes the cause of the distress.  
1.1.5. Drug induce hair loss 8 
 Drug can induce hair loss, but initially it is difficult to identify. The noxious 
substance may affect the growth phase of the hair growth cycle. There are two 
mechanisms of drug-induced alopecia. They are as follows, 
a) Direct effects 
Include anagen growth interruption, precipitation of catagen, and 
disturbed keratinization, resulting in hair shaft damage. 
b)  Indirect effects.  
Indirect effects include causing a systemic disease (hypothyroidism or 
zinc deficiency) or a severe skin disease (lichenoid eruption or toxic epidermal 
necrolysis) of which alopecia is a feature. 
 
Scalp follicles are in differing phases of the hair cycle and are randomly scattered 
over the scalp. Almost 90% of scalp follicles are in anagen, 10% in telogen, and 1% in 
catagen. Follicles are susceptible to noxious agents, usually when they are actively 
growing. During the anagen phase, the mitotic activity of the hair matrix is so high that it 
can be compared with the most actively kinetic tissues of the body, namely bone marrow 
and mucous membranes. For this reason anagen hair matrix is highly susceptible to 
noxious events. 
 Anticancer drug induced hair loss 
Adjuvant and metastatic Chemotherapy regimens often cause hair loss as a side 
effect. In studies conducted on breast cancer patients undergoing Chemotherapy, hair 
loss was considered traumatizing and distressing by patients, and one study found 
women thought the hair loss was more difficult than losing a breast. Hair loss as a result 
of chemotherapy is seen as a loss of privacy because it revealed to others that the patient 
is being treated by chemotherapy. Patients attributed an altered sense of self and a  
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1.2. STRUCTURE OF HAIR 9,10 
Hair follicles have a cyclic activity characterized by alter Nance of periods of hair 
shaft production and of resting; The hair cycle consists of different stages.(Fig. 1.1) 
1.2.1. The hair follicle 
The hair follicle (Fig. 1.3) is divided in two portions: 
 The upper follicle, permanent 
 The lower follicle, dynamic. 
The hair bulb, which is the deep bulbous portion of the hair follicle that 
surrounded the dermal papilla, contains the hair matrix which produces the hair shaft and 
its sheets (Fig.1.5).  
                                
                    
            
        Anagen VI               Catagen                 Telogen               Anagen I          Anagen II             Anagen IV/V Anagen VI 
 
                                                    Fig.1.1 Stages of hair growth cycle  
 
1.2.2. Hair Growth Cycle 11  
The hair growth cycle involve three stages.(Fig. 1.2) 
 Anagen -hair shaft production which lasts 2–6 years 
During the growth phase of the hair cycle, the hair shaft is created from 
rapidly proliferating matrix cells. 
The hair follicle actively produces the hair shaft. This phase is the longest of 
the hair cycle and its duration determines the length of the hair shaft. Due to the high 
mitotic rate of follicular matrix cells, the anagen phase is very sensitive to noxious 
insults. 
 Catagen-transitional phase which lasts 2–3 weeks 
It is characterized by apoptosis of the hair matrix cells and involution of the 
lower part of the follicle. During catagen, the hair bulb migrates from the 
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hypodermis to the mid dermis. 
 Telogen- Resting phase lasts about 3 months 
 During this phase hair shaft production is absent and the hair bulb is 
completely keratinized. Telogen phase, in the scalp follicles, lasts about 3 months 
but it is considerably longer in other body regions such as the lower limbs. The 
hair shaft remains anchored to the follicle during telogen. Hair shedding 
(teloptosis/exogen) usually occurs when the follicle re-enters a new anagen phase. 
In some follicles teloptosis (Fig.1.4) occurs before the end of telogen and the 
follicle remains empty for a certain period (kenogen). This may be due to a 
premature teloptosis or prolonged telogen duration. 
 
         Fig. 1.2 Hair Growth Cycle 
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         Fig. 1.3 Hair follicle.                                                                           Fig.   1.4 Teloptosis 
 
                                    
 
                                                           Fig.   1.5  Hair matrix 
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1.3 HERBAL FORMULATION 
 Ayurveda is one of the traditional medicinal systems of Indian. The philosophy 
behind Ayurveda is preventing unnecessary suffering and living a long healthy life. Ayurveda 
involves the use of natural elements to eliminate the root cause of the disease by restoring 
balance, at the same time create a healthy life-style to prevent the recurrence of imbalance. 
Herbal medicines have existed world-wide with long recorded history and they were used in 
ancient Chinese, Greek, Egyptian and Indian medicine for various therapies purposes. World 
Health Organization estimated that 80% of the word's inhabitants still rely mainly on 
traditional medicines for their health care. The subcontinent of India is well-known to be one 
of the major biodiversity centers with about 45,000 plant species. In India, about 15,000 
medicinal plants have been recorded, in which the communities used 7,000-7,500 plants for 
curing different diseases. In Ayurveda, single or multiple herbs (polyherbal) are used for the 
treatment. The Ayurvedic literature Sarangdhar Samhita’ highlighted the concept of 
polyherbalism to achieve greater therapeutic efficacy. The active phytochemical constituents 
of individual plants are insufficient to achieve the desirable therapeutic effects. When 
combining the multiple herbs in a particular ratio, it will give a better therapeutic effect and 
reduce the toxicity. This review mainly focuses on important of the polyherbalism and its 
clinical significance. 
The formulation in Ayurveda is based on two principles 
a. Use as a single drug and  
b. use of more than one drugs, 
The latter one is known as Poly Herbal Formulation (PHF). This key traditional 
therapeutic herbal strategy benefits from the combining of several medicinal herbs to achieve 
extra therapeutic effectiveness, usually known as polypharmacy or polyherbalism. 
Historically, the Ayurvedic literature “Sarangdhar Samhita” dated centuries ago in 1300 A. 
D. has highlighted the concept of polyherbalism in this ancient medicinal system. In the 
traditional system of Indian medicine, plant formulations and combined extracts of plants are 
chosen rather than individual ones. It is known that Ayurvedic herbals are prepared in a 
number of dosage forms, in which mostly all of them are Poly herbal formulation.(12) 
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 The active phytochemical constituents of individual plants have been well established, 
they usually present in minute amount and always, they are insufficient to achieve the 
desirable therapeutic effects. For this, scientific studies have revealed that these plants of 
varying potency when combined may theoretically produce a greater result, as compared to 
individual use of the plant and also the sum of their individual effect.8 
1.4 Herbal Remedies for hair loss 
Medicine from the nature is more beneficial than synthetic,  Long time use of 
synthetic agent inversely affect the physiological action leading to increase the  adverse 
effect, that point to view diminish the noxious effect of the substance replacing by alternative 
system of medicine. 
Herbs are promising to treat almost all disease in universe, hair loss more prone to age 
between 18 to 60.Some plants available for the treatment of hair loss 
Table 1.1 List of Plants For treatment of Hair loss 
S.no Biological Name Family  Part used  
2.  Aloe vera Liliaceae Juice 
3.  Abrus precatorius Fabaceae Seeds 
4.  Allium tubarosam Amaryllidaceae Seeds 
5.  Bacoba monnieri Plantaginaceae Leaves 
6.  Eugenia jambolana Myrtaceae Seeds and fruits pulp 
7.  Eclipta alba Asteraceae Whole plant 
8.  Hybiscus rosa sinencis  Malvaceae Leaves 
9.  Legenaria ceraria Cucurbitaceae Leaves 
10.  Phyllanthus emblica Phyllanthaceae Fruits 
11.  Phyllanthus niruri Phyllanthaceae Whole plant 
12.  Trichosanthes cucumerina Cucurbitaceae Leaves 
13.  Trichonella foenugreacum Fabaceae Seeds              
14.  Tridax procumbens Asteraceae                       Leaves 
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The poly herbs available in the form of various formulations are hair oil, hair 
gel, hair cream. 
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2. REVIEW OF LITERATURE 
 
The selection of plant for formulation based on the ability to promote the hair 
growth and restoring properties many plants with folklore claim for hair growth. Among 
those plant Lagenaria siceraria, Trichosanthes cucumerina, Tridax procumbens, has an 
ethno medical claim in treatment of hair loss. Hence the literature review of the plant was 
done to find out the nature of scientific evaluations carried out on those plants. 
 
Petchi RR et al. (2013) Anti]diabetic and antihyperlipidemic effects 13 
The ethanolic extract of whole plant of Tridax procumbens showed marked anti 
diabetic effect in streptozotocin and nicotinamide induced diabetic male wister rat and also 
inhibit the streptozotocin induced  weight loss and significantly alter the lipid level. 
 
Jachak SM et al. (2011) Anti-inflammatory, cyclooxygenase inhibitory and antioxidant 
activities 14 
The various solvent extract of Tridax procumbens arial part showed significant 
inhibition of rat paw edema at a medium dose of 200mg /kg. The different solvent methanol, 
ethanol and ethylacetate were used for extraction of the active compound. Among the 
different extract ethyl acetate was the most active. 
 
Al Mamun MA Hosen MJ et al. (2015)Tridax procumbens flavonoids promote osteoblast 
differentiation and bone formation.15 
The Tridax procumbens flavonoid tested on primary mouse calvarial osteoblasts. 
flavonoids from Tridax procumbens  showed  upregulation of bone hormones mainly 
osteocalcin. Osteocalcin play a major role in body’s metabolic regulation and bone building. 
Mainly suggested to the patient with bone loss associated disease such as osteoporosis. 
Saxena M et al.  (2013) in-vitro antioxidant activity isolated bioactive compounds from 
Tridax procumbens Linn.16  
The causes of many disease mainly cancer induced by free radicals, daily need to 
remove the free radicals from body by anti-oxidant. The present review shows a phyto-
constituent of Tridax procumbens possess significant anti-oxidant properties. The methanolic 
extract of plant further purified isolated by n-butanol soluble part and ethyl acetate soluble p
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art were quantified the total phenolic and total flavonoids. The isolated different fraction 
were employed for in vitro anti-oxidant effect by 1,1 Diphenyl,2-Picryl Hydrazyl (DPPH) 
assay. The n butanol soluble part and ethyl acetate soluble part possess a significant anti 
DPPH activity while comparable with the Standard ascorbic acid. 
Duangmano S et al.(2012) Cucurbitacin B inhibits human breast cancer17 
 The growth inhibitory effect of cucurbitacin B on breast cancer cells was assessed by MTT 
assay. The effects of cucurbitacin B on microtubules morphological structure and tubulin 
polymerization were analyzed using immunofluorescence technique and tubulin polymerization 
assay kit, respectively. Proteomic analysis was used to identify the target-specific proteins that 
involved in cucurbitacin B treatment. Some of the differentially expressed genes and protein 
products were validated by real-time RT-PCR and western blot analysis. Cell cycle distributions 
and apoptosis were investigated using flow cytometry Cucurbitacin B exhibited strong anti-
proliferative effects against breast cancer cells in a dose-dependent manner  
Sathesh Kumar S, et al. (2009)  Hepatoprotective effect of Trichosanthes cucumerina 18 
The methanolic extract of whole plant of Trichosanthes cucumerina was evaluated for the 
hepatoprotective activity against carbon tetrachloride induced hepatotoxicity in rats. Various 
biochemical parameters like alanine amino transferase, aspartate amino transferase, alkaline 
phosphatase, total bilirubin, total protein and albumin levels were estimated in serum as well as 
the glutathione and malondialdehyde levels in the liver were determined. Histopathological 
changes in the liver of different groups were also studied.  
 
Shah SL et al. (2012) Cardioprotective Activity of Methanol Extract of fruit of Trichosanthes 
cucumerina 19 
Cardiac toxicity by doxorubicin was manifested as body weight loss, elevated serum 
Lactate dehydrogenase (LDH) and serum creatine kinase MB (CK-MB), increased ST, QT and QRS 
complex, reduced blood pressure, and left ventricular function. The methanol extract of T. 
cucumerina significantly decreased LDH and CK-MB, reduced ST, QT interval and QRS 
complex, increased heart rate, restored blood pressure, and left ventricular function. Doxorubicin 
caused liver and kidney necrosis, cellular infiltration, and vascular changes that indicated injury. 
T. cucumerina (1000 mg/kg) reduced the severity of doxorubicin-induced cardiac damage 
especially in heart. It is concluded that doxorubicin-induced cardiotoxicity is reduced by 
pretreatment with methanol extract of fruit of T. cucumerina 
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Arawwawala LD et al. (2010) Gastroprotective activity of Trichosanthes cucumerina.20 
The hot water extract (HWE) of Trichosanthes cucumerina possesses significant dose 
dependent gastro-protective effects in the alcohol model in terms of the length and number of 
gastric lesions mediated by alcohol, with a maximum effect at 750 mg/kg . The same dose also 
mediated a significant gastro-protective activity in the indomethacine model. In both models, the  
 
protective effect demonstrated by the hot water extract was comparable with that produced by 
cimetidine. Trichosanthes cucumerina exerts a significant protection against ethanol or 
indomethacin induced gastric damage. Increase the protective mucus layer, decreasing the acidity 
of the gastric juice and antihistamine activity. 
 
Thube Smita et al. (2009)In-vitro Anthelmintic Activity of Seed Extract of Lagenaria 
siceraria21 
 Preliminary phytochemical screening of the crude extracts revealed the presence of 
sterols, proteins, carbohydrates, glycosides and saponins. The different extracts exhibited 
anthelmintic activity in dose dependent manner giving shortest time of paralysis (P) and 
death (D) with 100 mg/ml concentration. The methanolic extract of L.siceraria caused 
paralysis of 9 min and time of death of 17 min while benzene extract revealed paralysis of 12 
min and death of 22 min against the earthworm Pheritima posthuma. The reference drug 
Piperazine citrate showed the same at 20 and 45 minutes respectively. The traditional use of 
the seeds of L.siceraria as anthelmintic has been confirmed as the different extracts showed 
good anthelmintic activity in the study. 
  
Vishal R. Mali et al. (2010) Cardioprotective effect of Lagenaria siceraria (LS) fruit 
powder in isoprenalin-induced cardiotoxicity in rats22 
It is concluded that long period (51 days) administration of Lagenaria sicereria fruit 
powder reduced isoprenalin-induced tachycardia and prevented decrease in systolic BP. The 
cardiotoxic effect of isoprenalin was less in LS pretreated animals. The antioxidant and anti-
inflammatory activity of LS appears to contribute in the cardioprotective effect of LS in 
isoprenalin-induced cardiotoxicity  
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Prerona Saha et al. (2010) Antihyperglycemic activity of lagenaria siceraria 23 
The aerial parts of L. siceraria methanol extract can be considered as a potent source 
of antidiabetic agents, which may be attributed to the flavonoid and polyphenolic content of 
the extract. Additionally, it improves lipid metabolism and represents a protective 
mechanism against the development of atherosclerosis, and prevents diabetic complications 
from lipid peroxidation by improving the antioxidant status in experimental diabetic rats. 
 
Schlumbaum et al. (2012) A short history of Lagenaria siceraria (bottle gourd) in the 
Roman provinces24 
Lagenaria siceraria (Molina)  is pantropic and displays large variation in fruit and 
seed shape. Two subspecies are currently recognized, (i) The African L. 
siceraria ssp. siceraria and (ii) The Asian L. siceraria ssp. asiatica. The Asian type of 
bottle gourd belongs to the earliest domesticated plants in the Americas. In Europe, bottle 
gourd only appears with some frequency from the Roman period onwards. The paper is the 
study of ancient DNA (aDNA) and seed morphology of one almost complete bottle gourd 
fruit from the Roman site of Oedenburg/Biesheim–Kunheim, France (1st century A.D.), and 
from individual seed finds from the Roman vicus of Petinesca–Vorderberg, Switzerland 
(3rd century A.D.), both recovered from waterlogged layers. Width and length 
measurements of seeds show large variation.  
 
Kirana H, et al. (2008) Trichosanthes cucumerina Linn. improves glucose tolerance and 
tissue glycogen in non-insulin dependent diabetes mellitus25 
Non-Insulin Dependent Diabetes Mellitus (NIDDM) was induced by administering 
streptozotocin (90 mg/kg, i.p.) in neonatal rat model. NIDDM animals were treated with 
aqueous extract of Trichosanthes cucumerina (100 mg/kg/day) orally for six weeks. 
Parameters such as fasting blood glucose, Oral Glucose Tolerance Test (OGTT) and tissue 
glycogen content were evaluated. Aqueous extract of Trichosanthes cucumerina significantly 
(P<0.01) decreased the elevated blood glucose of NIDDM induced rats. 
 
Liyanage et al.(2016) Comparative Analysis of Nutritional and Bioactive Properties of 
Aerial Parts of Snake Gourd (Trichosanthes cucumerina Linn.)26 
The present investigation was carried out to determine the nutritional and functional 
properties of T. cucumerina. Water extracts of freeze dried flowers, fruits, and leaves of T. 
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cucumerina were evaluated for their total phenolic content (TPC), total flavonoid content 
(TFC), antioxidant activity, α-amylase inhibitory activity, and fiber and mineral contents. 
Antioxidant activity, TPC, and TFC were significantly higher in leaves than in flowers and 
fruits. 
Anbarasu K et al. (2011) Antipyretic, anti-inflammatory and analgesic properties of 
nilavembu kudineer choornam: a classical preparation used in the treatment of 
chikungunya fever 27 
 Ethanolic extract of nilavembu kudineer choornam in inflammation, pain and fever 
were carried out in animal models to support its actions. Acute toxicity study of ethanolic 
extract of nilavembu kudineer choornam was performed in mice to fix the effective dose. The 
antipyretic, anti-inflammatory and analgesic activity Ethanolic extract of nilavembu kudineer 
choornam was evaluated in brewer's yeast induced pyrexia in rats, carrageenan-induced 
inflammation in rats and acetic-acid induced writhing in mice model. The present findings 
revealed that Ethanolic extract of nilavembu kudineer choornam possesses antipyretic, anti-
inflammatory and analgesic activity which supports nilavembu kudineer choornam efficacy 
in chikungunya fever. 
Kenoth et al. (2011) Steady-state and time-resolved fluorescence studies on 
Trichosanthes cucumerina seed lectin28 
Steady-state and time-resolved fluorescence spectroscopic studies have been carried 
out on Trichosanthes cucumerina seed lectin. The fluorescence emission maximum of 
Trichosanthes cucumerina seed lectin in the native state as well as in the presence of 0.1 M 
lactose is centered around 331 nm, which shifts to 347 nm upon denaturation with 8 M urea, 
indicating that all the tryptophan residues of this protein in the native state are in a 
predominantly hydrophobic environment. 
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3. RATIONALE FOR SELECTION 
 Herbs combine to gather one formulation it gives better curative and therapeutic 
effect compare when being as a single drug.  
Plants not directly used as medicinal purpose, when it processed and formulated as any one of 
the suitable formulation  gives better therapeutic effect by means of dried powder form or 
extract from the plant with the advance technique. 
Gel formulation is a one of the topical formulation and it gives better absorption on 
the skin and less adverse effect comparable other formulation.  When the plant formulated as 
gel it gives better absorption through skin and gives maximum therapeutic.  
 
 Lagenaria siceraria is a small shrub under cucurbitaceae family. It is grow over 
the tropical and subtropical area and easily available. Lagenaria siceraria has various ethno 
botanical applications and medicinal claims. It fruits have been use vegetables and the 
ethanomedicinal uses of leaves shows hair growth activity 
Trichosanthis cucumarina , is a small shrub under cucurbitaceae family. It is grow 
over the tropical and subtropical area and easily available. Its ethanomedicinal uses shows 
action on hair growth. 
Tridax procumbens is a small weeds procumbent herb, Asteraceae family and 
easily available through the tropical and subtropical areas. Its leaves ethanomedical uses 
claim to have hair restoring properties. 
The review of the all plant shows good medicinal value. All the plants provide hair 
growth activity. Among topical formulation, the gel formulation is more suitable for 
topical application and produce cooling effects. 
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4. AIM AND OBJECTIVE  
 
 
 
 
 
 
 To perform phytochemical studies. 
 
DEVELOPMENT OF 
HERBAL GEL 
To develop and standardize 
herbal gel formulation 
PHARMACOLOGICAL 
EVALUATION 
Clinically evaluate hair growth 
activity of Poly Herbal Gel 
Formulation. 
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5. PLANT PROFILE  
1.3 Tridax Procumbence linn29 
7.1.1. COMMON NAME 
 English         : Coat buttons 
 Tamil            :Vettukaya-thalai 
 Telugu          : Raavanaasuruditalakaai 
 Keralam       : Gobbu sanna savanthi 
7.1.2. TAXONOMY 
KINGDOM                 : Plantae-plants 
DIVISION                  : Magnoliphyta-flowering plant 
CLASS                        : Magnoliopesida-dicotyledons 
ORDER                       :Asterasles 
FAMILY                     : Asteraceae-Aster family 
GENUS                       : Tridax L.-tridax 
SPIECES                    : Tridax procumbans lin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
               Fig.5.1 Whole plant of Tridax procumbens 
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7.1.3. GEOGRAPHICAL DISTRIBUTION 
Originally from Central America, the plant has become wide spread as a weed in 
tropical and subtropical regions30. 
7.1.4. HABITAT 
Sunny, dry locations, especially sandy and rocky sites like roadsides, 
railways, dunes, and waste places, at elevations up to 1,000 metres 
 
7.1.5. MORPHOLOY 
 Leaves  
The leaves are green in colour, characteristic odour,3-7cm long  ,1-5 cm 
wide, lanceolate to ovate shape, lamina pinnatisect sometime 3 lobed , short 
texture, acute apex, irregularly toothed margin, leaf are arranged opposite, the 
surface of the leaves rough and scabrous and short petiole. 
 Stem 
Green in colour, characteristic odour, acrid taste, 23 -46cm   
 
 Flower 
Flower are small,long-penduncled heads,rays florets strap shaped, 
white colour and disc florets yellow coloured ,achenes black, narrowly 
obconnical 2.0-2.5mm long with feathery papus. 
7.1.6. PHYTOCHEMICAL CONSTITUENTS 
Leaves contain protein, carbohydrate, β-sitosterol, tannin, fumaric 
acid,flavonoids. 
 
2.3 Lagenaria siceraria31 
Botanical name: Lagenaria siceraria 
Synonym  : Bottle guard 
Family              : Cucurbitaceae 
7.2.1. VERNACULAR NAME  
COMMONNAME:Bottle gourd 
Malayalam: Churakka, Peccura 
Tamil: Sorakkai 
Telugu: Sorakaya 
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Hindi: Titalanki 
Kannadam:Kadusore 
 
7.2.2. TAXONOMY 
Kingdom : Plantae 
Division : Magnoliophyta 
Class  : Magnoliopsida 
Order  : Cucurbitales 
Family  : Cucurbitaceae 
Genus  : Lagenaria 
Species : L. siceraria 
 
 
                      Fig. 5.2 lagenaria siceraria 
 
7.2.3. HABITAT AND HABITATION32 
It is obscure, though it is probably Asia or Africa. A plant of the moist, 
lowland tropics and subtropics .It can be grown at elevations up to 1,600 meters, but 
economic crops are only produced below 500 meters. 
7.2.4. MORPHOLOY33 
 
Stems  
Prostrate or climbing, angular, ribbed, thick, brittle, softly hairy, up to 5 m 
long, cut stems exude no sap.  
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Leaves  
 Simple, long petioled, 5-lobed, cordate, pubescent, shortly and softly hairy, 
broadly egg-shaped, kidney-shaped, or heart-shaped in outline, undivided, angular, or 
faintly 3–7 lobed, lobes rounded, margins shallowly toothed, crushed leaves 
nonaromatic. 
 Fruits  
Are large, variable, cylindrical, flask-shaped or globose with a constriction 
above the middle; fleshy, densely hairy, indehiscent, green, maturing yellowish or 
pale brown, pulp drying out on ripening, leaving a thick, hard, hollow.  
Seeds  
Many, embedded in a spongy pulp, compressed, with two flat facial ridges, in 
some variants rather irregular and rugose 
7.2.5. PHYTOCHEMICAL CONSTITUENTS 
The edible portion of the plant contains proteins, carbohydrates mineral 
matters calcium, phosphorus other mineral matters iron, sodium, potassium, iodine. 
Carbohydrates, amino acids, good source of B vitamins and poor source of ascorbic 
acid 
3.3 Trichosanthes cucumarina34,35  
Botanical name: Trichosanthes cucumarina 
Synonym  : Snake guard 
Family   : Cucurbitaceae 
7.3.1. VERNACULAR NAME  
  Common name: Khyar, Pudal, Snake Gourd, 
Sanskrit &Hindi: Chachinda, Janglipadvel, chachinga.  
Marathi  : Padwal  
Guajarati : Padavali 
Telugu :Lingapotla ,Potlakaaya(fruit) 
Tamil   :Pudalankaai ,Peipudal  
Kannada :Padavalakayi 
Beng.  :Chichinga 
Mal.  :patavalanga 
Punjab :galartori 
 
7.3.2. TAXONOMICAL CLASSIFICATION 
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KINGDOM   : Plantae (plantes, Planta, Vegetal, plants)  
DIVISION      : Tracheophyta – vascular plants, tracheophytes 
CLASS    : Magnoliopsida  
ORDER          : Cucurbitales.  
FAMILY : Cucurbitaceae  
GENUS : Trichosanthes L.  
SPECIES : Trichosanthes cucumarina var. anguina  
 
 
                           Fig.5.3 Trichosanthes cucumarina 
 
The Trichosanthis is wildly distributed around the tropical and subtropical areas ,south and 
southeast Asia including India, Bangladesh, Nepal, Pakistan, Sri Lanka, Indonesia, Malaysia, 
Myanmar, Sounthern China. 
7.3.3. HABITAT AND HABITATION 
The trichosanthis is wildly distributed around the tropical and 
subtropical areas, south and southeast Asia including India, Bangladesh, 
Nepal, Pakistan, Sri Lanka, Indonesia, Malaysia, Myanmar, Sounthern China 
Warm season crop but depending upon the locality, the vine thrives in 
rich, loamy soils, other soils with good drainage and rich in organic matter are 
suitable. 
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7.3.4. MORPHOLOGY 
 Leaf 
The leaves- are 5.8-12.5 cm long of various shapes, lobed, a little broader 
than long, orbicular reniform or broadly ovate, distantly denticulate, more or less 
deeply 5(rarely3-7) lobed, the lobes broad, acute, glabrous, less pubescent or 
when old sometimes scabrid beneath, base deeply cordate, the sinus often sub-
rectangular, petioles 2.5-7.5 cm long, striate, pubescent. 
  
 Stem  
  
Very long, Slender, furrowed, sub-glabrous, tendrils 
 
 Flower 
Monoecious, male flowers in axillary racemes, peduncles 5-115 cm long, 
bearing 8-15 flowers near the apex, female flowers axillar, solitary 
 Fruits 
Sometimes up to 4 meter in length and up to 7.5cm thick, often twisted, 
green when young, or pale green, white, sometime striped, changing to bright 
orange when ripe. 
7.3.5. PHYTOCHEMICAL CONSTITUENTS36,35 
Proteins, fat, fiber, other carbohydrates, minerals matter, calcium, oxalic acid, 
phosphorus, iron, magnesium,  sodium, potassium, copper, sulphur, chlorine, 
thiamine, riboflavin, nicotinic acid, vitamin c, carotene. The ripen fruits contain 
lycopene and β-carotene it have more antioxidant properties and which rich in fibre 
content. 
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6. PLAN OF WORK 
 Authentication 
 Collection of Plant 
 Drying of Plant 
 Herbarium of the plant 
 Phytochemical work 
 Physio-Chemical constants analysis 
 Preliminary chemical test 
a. Preliminary phytochemical screening of powders and 
extracts 
b. Fluorescence analysis of plants powder and  extracts 
   Extraction 
 Quantitative analysis 
 Determination of total flavonoid compounds 
 Determination of total phenolic compounds 
 Determination of antioxidant properties  
 Chromatography 
 Thin layer chromatography 
 Development of gel formulation 
 Preparation  of gel formulation 
 Standardization of gel formulation 
 
 PHARMACOLOGICAL STUDIES  
 Clinical evaluation of hair growth activity of formulated gel. 
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7. METHODOLOGY 
7.1 LIST OF MATERIALS AND THEIR USES IN FORMULATION 
The materials used in the study were as follows: 
Table 7.1 List of materials and their uses in formulation 
 
S.no Name of the Materials  Use in formulation 
1.  Legenaria siceraria (Leaves) Active Ingredient  
2.  Trichosanthes cucumerina(Leaves) Active Ingredient 
3.  Tridax procumbens (Leaves) Active Ingredient 
4.  Carbopol 934 Gelling agent  
5.  Povidone  Suspending agent  
6.  Polyethylene Glycol Moisturizing agent   
7.  Tuber rose oil Flavoring agent  
8.  Demineralized  Water Solvent  
 
7.2 PHYTOCHEMICAL STUDIES 
The Phytochemical investigation of a plant involves authentication and 
extraction of plant material; qualitative and quantitative evaluations; separation and 
Parallel to this may be the assessment of pharmacological activity. 
 
7.2.1. PHYSIO-CHEMICAL CONSTANTS 37,38,39 
Shade dried powdered plant materials for used for the determination of the physio 
chemical constants in accordance with the WHO guidelines. 
 
7.2.1.1. DETRMINATION OF ASH VALUES 
Ash values are helpful in determining the quality and purity of a crude drug in the 
powdered form. The residue remaining after incarnation is the ash content of the drug, 
which simply represents inorganic salts, naturally occurring drug or adhering to it or 
edibility added to it, as a form of adulteration. 
Ash value of a crude drug is defined as the inorganic residue remaining after 
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incineration, which complies of inorganic salts, naturally occurring in drug or adhering to it 
or deliberately added to it as a form of adulteration. Hence it is used for the determination of 
the quality and purity of the crude drug in the powdered form.  
 TOTAL ASH 
 Total ash method is designed to measure the total amount of material remaining after ignition.  
They include both physiological ash which is derived from plant tissue itself and non-physiological 
ash which is the residue of extraneous matter adhering to the plant surface. 
Procedure:  
 Silica crucible was heated to red hot for 30 minutes and cooled in the desiccators Incinerate 
about 2 to 3 g accurately weighed, of the ground drug in a tarred silica dish at a temperature not 
exceeding 4500C until the sample is free from carbon, cooled in desiccators and weighed. The ash 
obtained was weighed. The percentage of total ash was calculated.  
 WATER SOLUBLE ASH: 
The difference in weight between the total ash and the residue after treatment of the total ash in water.  
Procedure: 
 Total ash obtained is boiled for 5 minutes with 25 ml of water, insoluble matter were 
collected in an ashless filter paper, washed with hot water and ignite for 15 min at a temperature not 
exceeding 4500.  Subtract the weight of this residue in mg from the weight of total ash. Calculate the 
content of water-soluble ash in mg per gram of air-dried material.  
   Water soluble ash =  Weight of residue obtained    X 100 
      Weight of the sample taken  
 ACID INSOLUBLE ASH: 
 The residue obtained after boiling the total ash with dilute hydrochloric acid, the remaining 
insoluble matters are ignited and measured. This measures the amount of silica present, especially as 
sand and siliceous earth.  
Procedure:  
 To the crucible containing total ash of the sample, 25 ml of dilute hydrochloric acid is added. 
The insoluble matter is collected on an ashless filter paper (Whatman 41) and washed with hot water 
until the filtrate is neutral.  Filter paper containing the insoluble matter to the original crucible, dry on 
hot plate and ignite to constant weight. Allow the residue to cool in a suitable desiccators for 30 
minutes and weighed without delay. Content of acid-insoluble ash with reference to the air dried drug 
is calculated. 
  Acid insoluble ash =  Weight of the residue obtained    X 100 
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     Weight of the sample taken  
 SULPHATED ASH 
 Sulphated ash test is used to measure the amount of residual substance not volatilized from a 
sample. These tests are usually used to determine the content of inorganic substance.  
Procedure:  
 Silica crucible was heated to redness for 10 minutes, allowed to cool in a desiccator and 
weigh. 2 g of sample were accurately weighed, ignited gently then thoroughly chared. Cool, 
moistened the residue with 1 ml of sulphuric acid, heat gently until the white fumes are no longer 
evolved and ignite at 800 ± 25o until all black particles have disappeared. Crucible are allowed to 
cool,  add few drops of sulphuric acid and heat. Ignite as before, allow to cool and weigh. This 
process is repeated until two successive weighing differ by more than 0.5 mg.  
 Sulphated ash = weight of the residue obtained X 100 
   Weight of the sample taken 
7.2.1.2. DETERMINATION OF EXTRACTIVE VALUES: 
 Extractive values are useful for the evaluation of phytoconstituents especially when the 
constituents of a drug cannot be readily estimated by any other means. Further these values indicate 
the nature of the active constituents present in a crude drug. 
 Determination of water soluble extractive 
                     5gm of air dried coarsely powdered sample was weighed and macerated with 100ml of 
chloroform water (95ml distilled water and 5ml chloroform) in a closed flask for 24 hours. It was 
shaken frequently for six hours and allowed to stand for rest eighteen hours. It was then filtered 
rapidly, taking precautions against loss of solvent and 25ml of the filtrate was evaporated to dryness 
in a tarred flat bottomed shallow dish and was dried at 105°C for 1 hour in the hot air oven and cooled 
in desiccators for 30min and weighed. The process was repeated till a constant weight was obtained; 
the percentage of water soluble extractive value was calculated with reference to the air dried drug. 
    Water soluble extractive value =  Weight of the dried extract   X   100 
 Weight of the sample taken 
 Determination of alcohol soluble extractive 
                           5gm of the coarsely powdered sample was weighed and macerated with 100ml 90% 
ethanol in a closed flask for 24 hours. It was shaken frequently for six hours and allowed to stand for 
eighteen hours. It was then filtered rapidly, taking precautions against loss of solvent and 25ml of the 
filtrate was evaporated to dryness in a tarred flat bottomed shallow dish. It was dried at 105°C for 
1hour in a hot air oven. The dish was cooled in desiccator and weighed. The process was repeated till 
the constant weight was obtained. The percentage of alcohol soluble extractive value with reference to 
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the air dried drug was calculated. 
      Alcohol soluble extractive =  weight of the dried extract  X 100 
 weight of the sample taken  
 Determination of ether soluble extractive  
The type of ether soluble extractive values determined for evaluation of crud drug are volatile and 
non-volatile  ether soluble extractives. The volatile ether soluble represent volatile oilcontent of drug, 
while non-volatile ether soluble extractives represent resin, fixed oils or colouring matter present in 
drugs. The percentage of ether soluble extractive was calculated          
Ether soluble extractive    =   Weight of the dried extract   X 100 
       Weight of the sample taken 
7.2.1.3. DETERMINATION OF MOISTURE CONTENT: 
 LOSS ON DRYING 
                   10 g of the sample substances (without preliminary drying) was taken in a tarred 
evaporating dish.  Use of high speed mill in preparing the samples are avoided. The sample in the 
tarred evaporating dish were placed in the drying chamber (105°C) for 5 hours and weigh. Drying and 
weighing is continued every one hour interval until the difference between the two successive weight 
is not more than 0.25 percent. Constant weight is reached when the two consecutive weighing after 
drying for 30 minutes and cooling for 30 minutes in a desiccators, show not more than 0.001 g 
difference. Percentage moisture content is compared with respect to the air dried sample. 
 % Moisture content =  Final weight of the sample X  100 
     Initial weight of the sample 
 
7.2.2. PREPARATION OF EXTRACT 40 
Extraction is the preliminary step involved in the phytochemical studies.  
Based on solvent’s polarity metabolites are extracted and according to the solubility of 
the constituents in the solvent. The method of extraction is hot percolation method. 
 
 HOT PERCOLATION METHOD 
About 200g of coarsely powdered plant was extracted with solvents of 
increasing polarity like Hexane, Chloroform, Ethyl acetate and Ethanol at 60-70°C. 
Each extract was concentrated using rotary vacuum evaporator. The percentage yield, 
color and consistency of all the extracts were noted and were taken up for further 
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detailed phytochemical and pharmacological screening. 
 
7.2.3. QUALITATIVE PHYTOCHEMICAL ANALYSIS 41,42 
Qualitative analysis for various phytoconstituents in the dried powders and 
extracts all the raw materials were carried out using different reagents are mentioned 
below. 
 DETECTION OF ALKALOIDS 
Dragendroff’s Test 
The powder/extract was dissolved in 5ml of distilled water, to this 5ml of 2M 
Hcl was added. Then 1ml of Dragendroff’s reagent was added and examined for an 
immediate formation of an orange red precipitate. 
 
Mayer’s Test 
The powder/extract was mixed with little amount of dilute Hcl and Mayer’s 
reagent and examined for the formation of white precipitate. 
Wagner’s Test 
The powder/extract was mixed with Wagner’s reagent and examined for the 
formation of reddish brown precipitate. 
 
 DETECTION OF GLYCOSIDES 
Bontrager’s Test 
The powdered plant material/extract was boiled with 1ml of sulphuric acid in a 
test tube for few minutes. The solution was filtered while hot, cooled and shaken with 
equal volume of chloroform. The lower layer of the solvent was separated and shaken 
with half of its volume of dilute Ammonia. Formation of a rose pink to red colour in 
the ammoniacal layer indicates the presence of glycosides. 
 
Modified Bontrager’s Test 
The test material was boiled with 2ml of the dilute sulphuric acid. This was 
treated with 2ml of 5% freshly prepared aqueous ferric chloride solution for 5 min and 
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shaken with equal volume of chloroform .the lower layer of solvent was separated and 
shaken with half of its volume of dilute ammonia. Formation of a rose pink to red 
colour in the ammoniacal layer indicates the presence of glycosides. 
 
Legal’s Test 
The test material when treated with sodium nitroprusside in pyridine and 
methanolic alkali. Formation of a pink to blood red colour indicates the presence of 
cardiac glycosides. 
 
 DETECTION OF STEROIDS 
Liebermann-Buchards Test 
The powdered drug/extract was treated with few drops of acetic anhydride, 
boiled and cooled. Concentrated sulphuric acid was added from the sides of the test 
tube. If a brown ring is formed at the junction of two layers and upper layer turns 
green, it shows presence of steroids. 
 
Shinoda Test 
To the solution of extract few piece of magnesium turnings and drops of 
concentrated Hcl were added. If a pink crimson red or occasionally green to blue 
colour appears after few minutes, this indicates the presence of flavonoids. 
 
Alkaline reagent Test 
To the test solution, few drops of sodium hydroxide solution were added. If 
there is a formation of intense yellow colour which turns to colourless on addition of 
few drops of dilute acid, this indicates presence of flavonoids. 
 
 DETECTION OF CARBOHYDRATES 
Molisch’s Test 
To the test solution, few drops of alcoholic alpha-napthol and few drops of 
concentrated Sulphuric acid were added through the sides of the test tube. Appearance 
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of purple to violet colour ring at the junction indicates the presence of carbohydrates. 
 
Fehling’s Test 
The test solution was mixed with Fehling’s I and II, heated and examined for 
the presence of red colouration for the presence of sugar. 
 
 DETECTION OF PHENOL 
Ferric chloride Test 
A small quantity of powdered drug/ extract was dissolved in 2ml distilled water 
and a few drops of 10% aqueous ferric chloride solution was added and observed for 
appearance of blue or  green colour. 
 
 DETECTION OF PROTIENS 
Biuret Test 
The sample was treated with 5-8 drops of 1% w/w copper sulphate solution and 
1ml of 5% sodium hydroxide. If a violet colour is formed it indicates the presence of 
proteins. 
 
 DETECTION OF TANNINS 
Lead acetate Test 
The test solution was mixed with basic lead acetate solution and examined for 
formation of white precipitate. 
Ferric chloride Test 
A few drops of 5% aqueous ferric chloride solution was added to 2 ml of 
aqueous extract of the drug and examined for the presence of bluish black colour. 
 
 DETECTION OF SAPONINS 
A drop of sodium bicarbonate solution was added to the sample and the 
mixture was shaken vigorously and left for 3minutes. Development of any honey comb 
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like froth was examined. 
 
 DETECTION OF GUMS AND MUCILAGE 
A small quantity of powdered drug/extract was dissolved in 5 to 10 ml of acetic 
anhydride by means of heat, cooled and 0.05ml of concentrated Sulphuric acid was 
added. Formation of bright purplish red colour indicates the presence of gums and 
mucilage. 
 
 DETECTION OF FIXED OILS AND FATS 
A small quantity of extract was pressed between two filter papers. An oily stain 
on filter paper indicates the presence of fixed oils and fats. 
 
7.2.4. FLUORESCENCE ANALYSIS 43 
Fluorescence analysis was carried out in day light and in UV light. The 
powdered plant raw materials and their extracts were treated with various reagents and 
solvents to identify the presence of chromophores. The fluorescence was observed in 
day light and in short and long UV light 254nm and 365nm respectively. 
 
7.2.5. QUANTITATIVE ESTIMATION OF PHYTOCONSTITUENT 
 
 DETERMINATION OF TOTAL FAVONOIDS44 
 
METHODS 
Ultra Violet spectroscopy method was carried out for the determination of 
total flavonoids content. 
Preparation of Standard Stock solution 
 Accurately weighed 25 mg of Quercetin standard transferred to 100 ml of 
volumetric flask and dissolved with dimethyl sulfoxide (DMSO). The serial dilution 
(20mcg, 40mcg, 60mcg, 80 mcg, 100 mcg) were made with dimethyl sulfoxide. 
Preparation of Test Solution 
The leaf extract was weighed accurately equal to the weight of Standard 
Quercetin and transferred to 100 ml volumetric flask and the extract dissolved with 
dimethyl sulfoxide (DMSO). The dilution was made with dimethyl sulfoxide. 
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Procedure 
From the prepared solution of standard and test solutions 2ml was withdrawn 
from each concentration to the test tube and added equal volume of 2% Aluminium 
Chloride solution to every single concentration. Incubate the solution about 10 minute at 
ambient temperature. After 10 minute, Standard and sample solution measure the 
absorbance of spectrophotometrically at 435 nm with the standard and test sample 
solutions.  
 DETERMINATION OF TOTAL PHENOLIC CONTENT  
                   (Folin – Ciocalteu’s assay) 
• METHODS 
Ultra Violet spectroscopy method was carried out for the determination of 
total flavonoids content 
 
• PREPARATION OF 16 %Na2Co3 
16gm w/w of sodium carbonate dissolved in 100ml of water. 
 
• PREPARATION OF STANDARD 
40mg of Gallic acid standard transferred 100ml of standard flask, Add to this 50 ml 
distilled water and shake well until the sample dissolved. Made volume with distilled water 
and withdrawn 10ml of the above solution into 100ml standard flask then make up to volume 
with distilled water. 
 
• PREPARATION OF TEST SOLUTION   
The 1gm of extract transferred to 250ml of flask, Add to this 50ml of water and heated on a 
water bath about 45 minutes. Then the solution was cool and made up to volume with distilled water, 
the solution was centrifuged at 5000rpm about 20 minutes. Then 2ml of superatted liquid transferred 
to 25ml of flask then made volume with water 
 
• BLANK    Purified water 
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• PROCEDURE   
 Pipetted out 2ml of Standard/test/blank to 25 ml of standard flask. 
 To the above solution add 1 ml of folin-ciocalteu’s reagent and made upto volume 
with saturated 16% of Sodium Carbonate solution. 
 Kept the solution aside about 30 minutes. 
 Absorbance of the solution was measured against blank by Spectrophotometrically at 
760nm 
 
7.3. DEVELOPMENT AND STANDARDISATION OF POLY HERBAL 
FORMULATION 46,47,48,49 
The prepared extracts were taken for the preparation of topical gel with water soluble 
gelling agent Carbopol 934, Propylene glycol 400, Povidone, Glycerin, Distilled water. 
 
Method for Preparation of Gel Containing Extracts (1% w/w) 
1 g of Carbopol 934 was dispersed in 50 ml of hot distilled water with continuous 
stirring. 5ml of distilled water was taken and required quantity of povidone was dissolved. 
Cool the solution, then to that added Propylene glycol 400. Further required quantity of 
prepared leaves extracts were mixed to the above mixture and volume made up to 100 ml by 
adding remaining distilled water. Finally full mixed ingredients were mixed properly to the 
Carbopol 934 gel with continuous stirring and tri-ethanolamine was added drop wise to the 
formulation for adjustment of required skin pH (6.8-7) and to obtain the gel at required 
consistency.                              Table 7.2 Formula for gel preparation 
Ingredients Quantity Specified 
Carbopol-934 1 g 
Propylene glycol-400 Quantity sufficients 
Povidone 5% 
Triethanolamine 1.2ml(quantity sufficient) 
Distilled water Make up to 100 
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Standardisation of Topical Gel Formulation 
• Physical Evaluation   
Physical parameter(50)s such as colour and appearance were checked. 
• Measurement of pH 
pH of the gel was measured by using pH meter. 
• Spreadability 
Spreadability of the prepared gel was determined by wooden block and glass 
slide apparatus. 
 
Apparatus consists of a wooden block, which was provided by a pulley at one end. 
Spreadability was measured on the basis of slip and drag characteristics of gels. An excess of 
gel (about 2g) under study was placed on this ground slide. The gel was then placed between 
this slide and another glass slide having the dimension of fixed ground slide and provided 
with the hook. A 1 kg weighted was placed on the top of the two slides for 5 minutes to expel 
air and to provide a uniform film of the gel between the slides. Excess of the gel was 
scrapped off from the edges. The top plate was then subjected to pull of 80gms. With the help 
of string attached to the hook and the time (in seconds) required by the top slide to cover a 
distance of 7.5 cm be noted. A shorter interval indicates better Spreadability. 
 
Spreadability was calculated using the following formula: 
S = M × L / T 
Where, S = Spreadability,  
M = Weight in the pan (tied to the upper slide), 
 L = Length moved by the glass slide and 
 T = Time (in sec.) taken to separate the slide completely each other. 
 
Viscosity 
Viscosity of gel was measured by using Brookfield viscometer with spindle. 
Homogeneity 
All developed gels were tested for homogeneity by visual inspection after the gels 
have been set in the container. They were tested for their appearance and presence of any 
aggregates.  
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Skin irritation test  
Test for irritation was performed on human volunteers. The prepared gel was applied 
on area of 2 square inch to the back of hand to volunteers who are selected for the evaluation 
of hair growth gel. The volunteers were observed for lesions or irritation.  
 
7.4. CLINICAL EVALUATION OF HAIR GROWTH 51, 
The permission for the clinical study was granted by the Institutional ethical committee. 
The committee approved the proposal and granted the,  
                                     Certificate NO. 3112206, Dated 14.12.2016  
The prepared and standardized gel formulation was evaluated clinically. The clinical 
evaluation carried out in the Department of Dermatology, Rajivgandhi Government General 
Hospital, Chennai. 
Selection of human volunteers  
 Inclusion Criteria 
• Both female and male, whose age is more than 18 years  
• Patients, who are willing to give written, signed and dated informed consent to 
participate in the study. 
• Patients who are clinically diagnosed for diffuse hair loss are included in this 
study.  
             Exclusion Criteria 
• Pregnant or breast feeding or planning to become pregnant during the study 
period. 
• Known case of hypersensitivity investigational drug content. 
• Patients using any other treatment for this indication at the same time. 
• Received any other investigational medicinal therapy within 30 days and topical 
therapy within 7 days prior to screening. 
• Patients suffering from any active general illness or have history of any general 
illness. 
After the Selection of human volunteer, the nature of study was explained and they were 
request to read and sing both the informed consent form and information sheet. The 
consent form and information designed as follows          
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 INFORMED CONSENT FORM 
Name of the Participant: 
Name of the Principal (Investigator): 
Name of the Institution: 
Documentation of the informed consent  
 I      --------------------------- have read it has been for me, the information in this 
form. I was free to ask any questions and they have been answered. I am over 18 
years of age and exercising my free power of choice, here by give my consent as a 
participant in the study. 
 I have read and understood this consent form and the information provided to me. 
 I have had the consent document explained to me. 
 I have been explained about the nature of the study. 
 I have been explained about the rights and responsibilities by the investigator. 
 I am aware of the fact that I can opt out of the study at any time without having to 
give any reason and this will not affect my future treatment in this hospital. 
 I hereby give permission to the investigators to release the information obtained 
from me as a result of participation in this study to the regulatory authorities, 
government agencies and Institutional ethics Committee. I understand that they are 
publicly presented. 
 I have understood that my identity will be kept confidential if any data are publicly 
presented. 
 I have had my questions answered to my satisfaction. 
 I have decided to be in the research study. 
 I am aware that if I have any question during this study, I should contact at one of 
the addresses listed above. By signing this consent for I attest that the information 
given in this document has been clearly explained to me and apparently understood 
by me. I will be given a copy of this consent document. 
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 INFORMATION SHEET 
Investigator: 
Name of the Participant: 
 You are invited to take part in this study. The information in this document is 
meant to help you decided whether or not to take part. Please feel free to ask if you 
have any queries or concerns  
 We are conducting a study on “DEVELOPMENT AND STANDARDIZATION 
OF POLY HERBAL GEL FORMULATION AND ITS CLINICAL STUDIES” 
among the patients attending Rajive Gandhi Government Hospital, Chennai 
 And for that your participation may be valuable us. 
 The purpose of the study is to determine the hair growth stimulation of the poly 
herbal gel formulation and to determine the effectiveness of the poly herbal gel 
formulation. 
 The patient will be subjected to determine the hair growth efficiency before and 
after application of the herbal gel and the measurement of hair growth at interval of 
7 days initially and later it will extended to 15 days. 
 The privacy of the patients in the research will be maintained throughout the study. 
In the event of any publication or presentation resulting from the research, no 
personally identifiable information will be shared. 
 Taking part in this study is voluntary. You are free to decide whether to participate 
in this study or to withdraw at any time; your decision will not result in any loss of 
benefits to which you are otherwise entitled. 
 The result of the special study may be intimated to you at the end of the study 
period or during the study if anything is found abnormal which may aid in the 
management or treatment. 
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Study groups and duration of study 
                       30 volunteers selected according to the inclusion criteria. They are to be 
divided into 2 groups control and test. The control group receives gel without extract 
medication. The test group receives the formulated herbal gel. Duration of the study is 
90days.  
Pre evaluation parameter of volunteers 
• Measurement of hair texture, examined by simple method of touching the 
patient’s hair, 
• Hair density/cm.sq area :examined at a fixed site of scalp with Trichoscope 
• Hair loss: counted after constant combing of patient’s hair for one minute with the 
comb 
Application of gel 
              The formulated gel is applied over the scalp during the course of study. If there is 
any sign of irritation or discomfort to the patient, the gel is discontinued. 
Evaluation parameters for hair growth (During the period of study) 
• Measurement of hair texture, examined by simple method of touching the 
patient’s hair, 
• Hair density/cm.sq area :examined at a fixed site of scalp with Trichoscope 
• Hair loss: counted after constant combing of patient’s hair for one minute with the 
comb 
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8. RESULTS AND DISCUSSION 
8.1. PHYSIO-CHEMICAL CONSTANTS. 
8.1.1. ASH VALUE 
Physiochemical parameters are mainly used in the assessment of purity and 
quality of the powdered drug. Ash values of a drug give an idea of the earthy matter 
or inorganic elements and other impurities present along with the drug. 
Ash values are mainly used in judging the purity and quality of the drug is the 
indicative of contamination, substitution and adulteration. The total ash usually 
consists of carbonate, phosphate and silicates. Total ash, acid insoluble ash and water 
soluble ash were done and reported in the table below. 
 Total ash 
 The total ash content of the raw materials were determined, taking sample 
from the Collected materials.(Table 8.1) 
 
                                                            Table 8.1 Total Ash Value 
Values are expressed as Mean ± SD, n=3 
 Acid insoluble Ash 
From the total ash, the acid insoluble ash content of the individual raw materials were 
determined and results enumerated.(Table 8.2) 
 
                      Table 8.2 Acid Insoluble ash Value 
 
Values are expressed as Mean ± SD, n=3 
S.NO Ingredient  
 
Total ash (%w/w) *Limits (%w/w) 
1. Legenaria siceraria (Leaves) 9.3±1.8 Not more than 12 
2. Trichosanthes cucumerina (Leaves) 8.6±1.2 Not more than 15 
3. Tridax procumbens (Leaves) 10.6±0.9 Not more than12 
S.NO        Ingredient    Acid insoluble ash (%w/w) *Limits (%w/w) 
1. Legenaria siceraria (Leaves)           0.5±1.2 Not more than 0.6 
2. Trichosanthes cucumerina(Leaves)            1.4±1.5 Not more than2.5 
3. Tridax procumbens (Leaves)         3.01±2.5 Not more than 3.5 
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 Sulphated Ash 
Sulphated content of raw materials was determined, the values obtained and their 
acceptable limits defined are given.( table.8.3) 
                            Table 8.3 Sulphates Ash 
 
Values are expressed as Mean ± SD, n=3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.NO Ingredient  
 
Sulphated ash (%w/w) *Limits (%w/w) 
1. Legenaria siceraria (Leaves) 8.2±1.3 Not more than10 
2. Trichosanthes cucumerina(Leaves) 7.3±1.7 Not more than 8 
3. Tridax procumbens (Leaves) 11.6±2.1 Not more than 20 
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8.1.2. DETERMINATION OF EXTRACTIVE VALUE 
 Water Soluble Extractive 
Water soluble extractive values for the raw materials in water were determined and the results 
were given.( Table 8.4) 
             Table 8.4 Water soluble extractive value for Raw materials 
S.NO Ingredient  Water Extractive value (%w/w) *Limits (%w/w) 
1. Legenaria siceraria (Leaves) 26.3±16 Not less than 25 
2. Trichosanthes cucumerina 
(Leaves) 
20.6±1.3 Not less than18 
3. Tridax procumbens (Leaves) 21.4±2.1 Not less than 20 
   Values are expressed as Mean ± SD, n=3 
 
 Alcohol Soluble Extractive 
Alcohol soluble extractive values for the raw materials in ethanol 95% were determined and 
the results were given in table       
  Table 8.5 Alcohol soluble extractive value for Raw materials 
S.NO Ingredient  
 
Alcohol Extractive value (%w/w) *Limits (%w/w) 
1. Legenaria siceraria 
(Leaves) 
16.3±1.2 Not less than 10 
2. Trichosanthes cucumerina 
(Leaves) 
11.2±1.4 Not less than 8 
3. Tridax procumbens 
(Leaves) 
12.6±0.9 Not less than 12 
Values are expressed as Mean ± SD, n=3 
 
 
 
                                                                          Result and Discussion 
 
 
 
Department of Pharmacognosy, MMC, Chennai-3 Page 42 
  
 
   
 Ether Soluble Extractive 
Ether soluble extractive values for the raw materials in ether were determined and the results 
were given in table    
                       Table 8.6 Ether soluble extractive value for Raw materials 
S.NO Ingredient  
 
Ether soluble Extractive value (%w/w) *Limits (%w/w) 
1. Legenaria siceraria 
(Leaves) 
2.1±0.8 Not less than 1 
2. Trichosanthes cucumerina 
(Leaves) 
1.9±1.2 Not less than 1.5 
3. Tridax procumbens 
(Leaves) 
2.7±1.6 Not less than 2 
Values are expressed as Mean ± SD, n=3 
 
8.1.3. MOISTURE CONTENT 
 
Loss on Drying  
Loss on dry analysis in the raw materials were carried out and the results were recorded and 
results in Table 8.7 
                     Table 8.7 Loss on Drying 
S.NO Ingredient  
 
LOD (%w/w) *Limits (%w/w) 
1. Legenaria siceraria 
(Leaves) 
4.8 Not more than15 
2. Trichosanthes cucumerina 
(Leaves) 
6.3 Not more than 15 
3. Tridax procumbens 
(Leaves) 
8.4 Not more than 15 
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8.2. PREPARATION OF EXTRACTS 
The shade dried all plants materials raw were extracted in soxhlet extractor 
with the universal solvent ethanol.  All the extracts were concentrated using rotary 
vacuum evaporator. The percentage yield was calculated for every extract in terms of 
dried weight of plant materials. The colour and consistency of the concentrated 
extracts are given in table no.2 
Table 8.8 Percentage yield of extracts 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.NO 
PLANT 
NAME SOLVENT 
METHOD OF 
EXTRACTION 
PHYSICAL 
NATURE 
COLOUR YIELD 
(%W/W) 
1.  Legenaria 
siceraria 
(Leaves) 
 
 
    Ethanol     
    (95%) 
 
 
Continuous Hot 
percolation 
method using 
Soxhlet apparatus 
 
Semisolid 
 
Dark green 
 
     5.58 
2.  Trichosanthes 
cucumerina 
(Leaves) 
 
Semisolid 
 
Dark green 
 
     4.76 
3.  Tridax 
procumbens 
(Leaves) 
 
Semisolid 
 
Dark green 
 
     6.46 
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8.3. QUALITATIVE ESTIMATION OF PHYTOCONSTITUENTS 
The raw material powders and all the extracts were subjected to qualitative 
phytochemical analysis to identify the various phytoconstituents present in it, as per the 
standard procedures. The results are given in the Table 8.8  
 
Table 8.8 Preliminary phytochemical analysis of powder and extracts of 
raw materials 
 
Chemical 
constituents 
Lagenarria 
siceraria 
Trichosanthes 
cucumerina  
Tridax 
procumbens 
Powder Extract Powder Extract Powder Extract 
Steroids         + + + + - - 
Glycosides - - - - + 
 
+ 
 
 
Saponins - - - - -  
Flavonoids + + + + + + 
Tannins + + + + + + 
Proteins          + + + + - - 
Alkaloids - - - - - - 
Carbohydrates + + + + + + 
 
Terpenoids - - - - - - 
Fats and oils - - + + - - 
+ indicates presence , - indicates absence 
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8.4. FLUORESCENCE ANALYSIS 
Fluorescence analysis for the extracts and the powdered drug were carried out 
with various reagents to identify the presence of chromophores. The importance of 
fluorescence analysis is that UV light shows the fluorescent nature of the compound 
whereas fluorescence cannot be observed in day light. Hence it is performed 
according to the standard procedures. The results are shown in Table 8.9 
                               Table 8.9 Fluorescence analysis of Lagenaria siceraria 
TREATMENT  DAY LIGHT  SHORT UV (254 nm)  LONG UV (365 nm)  
Drug Green Green  Dark green 
Saturated picric acid Yellowish green Dark green  Yellowish-black 
Nitric acid Radish- brown Light brown Brown 
Hydrochloric acid Green  Block  Block  
Sulphuric acid 
(80%) 
Block  Block  Block 
Glacial acetic acid Dark green  Green  Block  
Iodine solution 
(N/20) 
Dark green Dark green Dark Brown 
Ferric solution (5% 
W/V aq. Solution) 
Yellowish brown Dark Brown  Dark Brown  
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Table 8.10: Fluorescence analysis of Ttichosanthes cucumerina 
 
TREATMENT  DAY LIGHT  SHORT UV (254 nm)  LONG UV (365 nm)  
Drug Green Green  Dark green 
Saturated picric acid Yellowish green Dark green  Yellowish-black 
Nitric acid Radish- brown Light brown Brown 
Hydrochloric acid Green  Block  Block  
Sulphuric acid 
(80%) 
Block  Block  Block 
Glacial acetic acid Dark green  Green  Block  
Iodine solution 
(N/20) 
Dark green Dark green Brown 
Ferric solution (5% 
W/V aq. Solution) 
Yellowish brown Dark Brown  Dark Brown  
 
 
Table 8.11: Fluorescence analysis of Ttridax procumbens 
 
TREATMENT  DAY LIGHT  SHORT UV (254 nm)  LONG UV (365 nm)  
Drug Green Green  Dark green 
Saturated picric acid Yellowish green Dark green  Yellowish-black 
Nitric acid Radish- brown Light brown Brown 
Hydrochloric acid Green  Block  Block  
Sulphuric acid 
(80%) 
Block  Block  Block 
Glacial acetic acid Dark green  Green  Block  
Iodine solution 
(N/20) 
Dark green Dark green Brown 
Ferric solution (5% 
W/V aq. Solution) 
Yellowish brown Dark Brown  Dark Brown  
 
No fluorescence was observed for the powder as well as extracts indicating the absence of 
chromophore in the plant. 
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8.5. QUANTITATIVE ESTIMATION  
 TOTAL FLAVONOID CONTENT 
The determination of total flavonoids from various extracts of Lagenaria siceraria, 
Trichosanthes cucumerina, tridax procumbens were performed with the Quercetin standard. 
The accuracy of test made by the serial dilution of Standard and the absorbance was 
measured spectrophotometrically at 435 nm (Table8.12). The obtained data were plotted as a 
Standard Calibration curve (Fig.1). 
 
Standard Calibration Curve for Quercetin 
To determine the accuracy of the flavonoid compound by plotted the standard 
absorbance obtained from spectrophotometrically. The calibration curve done by made serial 
dilution (20mcg, 40mcg, 60mcg, 80 mcg, 100 mcg) of quercetin Standard stock solution, the 
absorbance plotted against concentration 
 
Table 8.12: Spectrophotometric absorbance of Standard and Sample 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                              
 
 
 
 
 
  S.No Concentration of standard 
solution(µg/ml) 
Absorbance(435nm) 
1. 20 0.135 
2. 40 0.175 
3. 60 0.213 
4. 80 0.306 
5. 100 0.347 
6. Lagenaria siceraria 0.178 
7. Trichosanthis cucumarina 0.165 
8. Tridax procumbens 0.159 
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                          Figure 8.1: Standard Calibration Curve for Quercetin 
 
            
                
 
From the replicate absorbance value obtained by the spectrophotometry, the 
calculation of concentration of flavonoid present in 1gm of the extract was calculated by 
applying the dilution factor. The concentration of each extract obtained (Table 8.13) 
        
                   Table 8.13 Percentage yield of total flavonoid  
S.NO Sample Concentration 
Obtained (mg/gm) 
Percentage of Flavonoids  
Present 
1.  Lagenaria siceraria 43.43 4.3 
2.  Trichosanthis cucumarina 39.85 4 
3.  Tridax procumbens 33.72 3.4 
 
 
 
 
 
 
y = 0.0028x + 0.0687
R² = 0.9726
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0 20 40 60 80 100 120
Ab
so
rb
an
ce
Concentration µg/ml
Determination of Flavanoids 
Quercetin
Linear (Quercetin)
                                                                          Result and Discussion 
 
 
 
Department of Pharmacognosy, MMC, Chennai-3 Page 49 
  
 
   
 
 TOTAL PHENOLIC CONTENT   
Total phenolic content of the individual extract was determined and compared 
with that of standard.  It is shown in table 8.14 
 
Table 8.14 Spectrophotometric absorbance of Standard and Sample 
 
 
 
 
 
 
 
 
 
 
 
 
 
Standard Calibration Curve for Gallic acid 
To determine the accuracy of the phenolic compound by plotted the standard 
absorbance obtained from spectrophotometrically. The calibration curve done by made serial 
dilution (20mcg, 40mcg, 60mcg, 80mcg) of Gallic acid Standard stock solution, the 
absorbance plotted against concentration 
                          
                      
 
 
 
 
 
 
 
                        
 
 
  S.No Concentration of 
Standard Solution(µg/ml) 
Absorbance(435nm) 
1.  20            0.156 
2.  40 0.194 
3.  60 0.304 
4.  80 0.390 
5.  Lagenaria siceraria 0.266 
6.  Trichosanthis cucumarina 0.231 
7.  Tridax procumbens 0.216 
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                          Figure 8.2: Standard Calibration Curve for Gallic acid 
 
       
 
 
From the replicate absorbance value obtained by the spectrophotometry, the 
calculation of concentration of phenolic content present in 1gm of the extract was calculated 
by applying the dilution factor. The concentration of each extract obtained (Table 8.15) 
 
Table 8.15 Percentage of phenolic content present in each extract 
S.NO Sample Concentration 
Obtained (mg/gm) 
Percentage of phenolic content 
Present(%w/w) 
1.  Lagenaria siceraria 204.33 20.4 
2.  Trichosanthis cucumarina 168.27 16.8 
3.  Tridax procumbens 108.17 10.8 
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          Table 8.16   STANDARDIZATION OF PREPARED POLY HERBAL GEL 
S. No. Parameters Results 
1.  Physical appearance   Light green 
2.  pH 7.1 
3.  Spreadability Good 
4.  Viscosity 43560 cps 
5.  Homogeneity Excellent   
6.  Skin irritation test No irritation 
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CLINICAL EVALUATION OF HAIR GROWTH 
The prepared and standardized ploy herbal gel formulation was tested on human 
volunteers. Before the clinical evaluation was carried out ethical clearance was approved by 
Institutional Ethical Committee. The hair length and diameter was measured by trichoscope 
and the results were tabulated. 
Every testing interval the patients scalp photos taken with the trichoscope (Fig8.3, 
Fig.8.4).The number of hair present in scalp was counter as per square area. 
    The obtained mean value from hair count in 1 cm square area for test group was 
plotted on graph 
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                           Figure 8.3 Hair in Scalp 
 
 
                         Figure 8.4 Hair in Scalp 
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                        Table 8.17    Hair count in per square area in test group 
No. of 
volunteers 
Initial After 15 days After 30 days After 60 days  After 90 days 
1.  15 15 20 26 37 
2.  10 10 15 20 27 
3.  13 12 16 18 29 
4.  9 10 12 18 25 
5.  15 16 19 22 30 
6.  12 10 15 18 22 
7.  9 9 14 19 24 
8.  15 13 16 24 33 
9.  10 9 12 20 25 
10.  8 8 11 15 21 
11.  10 11 14 19 19 
12.  14 15 17 17 20 
13.  12 13 16 20 29 
14.  16 17 18 20 23 
15.  13 13 17 17 24 
Mean 12.07±2.6 12.07±2.8 15.5±2.6 19.5±2.8 25.9±5.0 
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                                               Fig.8.5 Mean No. of Hair count
                      Mean No. of hair count in/cm. sq. area for Test group 
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  Table 8.18   Hair count in per square area in control group 
No. of 
volunteers 
Initial 0 
days 
After 15 days After 30 
days 
After 60 
days  
After 90 
days 
1.  10 10 12 14 13 
2.  14 13 13 15 15 
3.  10 11 11 12 12 
4.  7 7 8 7 7 
5.  15 14 17 16 16 
6.  13 11 11 13 14 
7.  11 11 12 14 14 
8.  12 12 14 15 15 
9.  14 13 14 14 16 
10.  8 8 10 10 11 
11.  12 12 11 13 13 
12.  11 11 14 15 14 
13.  12 14 14 15 15 
14.  9 10 9 11 11 
15.  13 13 13 14 14 
Mean value 11.4±2.3 11.3±2.02 12.2±2.3 13.2±2.4 13.3±2.35 
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                  Fig 8.6 Mean No. of hair count For Control Group 
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The hair growth activity of the prepared gel formulation was tested on human 
volunteers and growth activity was compared with the control group. The obtained mean 
value (Table 8.18) from both test and standard group were compared Fig 
                             
 
 
                Table 8.18    Meant value of hair count 
No. of Days Test Group Control Group 
0 12.07±2.6 11.4±2.3 
15 12.07±2.8 11.3±2.03 
30 15.5±2.6 12.2±2.3 
60 19.5±2.8 13.2±2.4 
90 25.9±5.0 13.3±2.4 
                                   Values are expressed as Mean ± SD, n=15 
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Fig. 8.7Comparison of hair growth of Test with Control 
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   Table 8.19    Mean number of hair loss in Combing test 
Parameter Group Initial 0 
days 
After 15 
days 
After 30 
days 
After 60 
days 
After 90 
days 
Mean hair loss 
(/combing) 
Test 114.5± 6.4 80.4± 12.4 78.2± 11.4 69.3± 10.4 51.5± 15.4 
Control 113.2± 6.4 109.2± 6.4 103.4± 6.7 99.9± 7.9 95.2± 6.8 
Perceptible 
Reduction in 
hairloss by 
Patients(%) 
Test - 34.1% 38.6% 45.2% 63.1% 
Control - 4.0% 10.4% 13.7% 18.0% 
                              
                      Fig. 8.8 Determination of  Reduction of Hairloss 
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Table 8.20     Measurement of density 
Group Initial    Mean 
density /cm.sq 
area (mm) 
Mean density 
/cm.sq area 
After 15 days 
(mm) 
Mean density 
/cm.sq area 
After 30 days 
(mm) 
Mean density 
/cm.sq area 
After 60 days 
(mm) 
Mean density 
/cm.sq area 
After 90days 
(mm) 
Test  0.09±0.16 0.14±0.14 0.13±0.17 0.14±0.16 0.14±0.2 
Control 0.08±0.17 0.07±0.16 0.08±0.18 0.11±0.10 0.11±0.14 
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9. SUMMARY AND CONCLUSION 
 
 Phytochemical Studies 
 
 The phytochemical constant were carried out for the plants powder and extracts  of 
Lagenaria siceraria, Trichosanthis cucumarina, Tridax procumbens to bring the quality and 
purity of the valuable medicinal plants 
 
 Preliminary phytochemical screening were carried out for all the plants and its 
extracts to determine the presence of active principle in plants 
  
 Fluorescence analysis was carried out to detect the presence of chromophore present 
in the powder and extracts. No fluorescence was observed for powder as well as extracts 
Selected plants powder were extracted with ethanol to bring all the active principle 
  
 Qualitative estimation of total flavonoid contend and total Phenolic content were 
determined by spectrophotometrically all the extract showed significant amount of flavonoid 
and phenolic compounds 
 
 Development and Standardization of formulation 
 Poly herbal gel was prepared with water soluble polymer Carbopol, propylene glycol 
400, povidone, triethanolamine to bring a good absorption capacity of the plant extracts on 
scalp. 
 The standardization parameters of the gel are viscosity, pH, Homogeneity, 
Spreadability, content uniformity, skin irritation test all were carried out to bring a quality, 
purity and safety of the prepared gel formulation 
 Clinical evaluation of hair growth activity 
 The prepared poly herbal formulation was taken for the determination of hair growth 
activity of the selected plants 
 The clinical evaluation of prepared gel was carried on the human volunteers and 
compared with the reference who applied gel without the extract. The growth of hair 
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measured by trichoscope and the growth was completely observed after the 90 days 
Hence, from these studies it is concluded that the prepared poly herbal gel containing Lagenaria 
siceraria, Trichosanthis cucumarina, Tridax procumbens proved hair growth activity 
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